» Articles » PMID: 33139480

Targeting the Achilles' Heel of Bacteria: Different Mechanisms To Break Down the Peptidoglycan Cell Wall During Bacterial Warfare

Overview
Journal J Bacteriol
Specialty Microbiology
Date 2020 Nov 3
PMID 33139480
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Bacteria commonly live in dense polymicrobial communities and compete for scarce resources. Consequently, they employ a diverse array of mechanisms to harm, inhibit, and kill their competitors. The cell wall is essential for bacterial survival by providing mechanical strength to resist osmotic stress. Because peptidoglycan is the major component of the cell wall and its synthesis is a complex multistep pathway that requires the coordinate action of several enzymes, it provides a target for rival bacteria, which have developed a large arsenal of antibacterial molecules to attack the peptidoglycan of competitors. These molecules include antibiotics, bacteriocins, and contact-dependent effectors that are either secreted into the medium or directly translocated into a target cell. In this minireview, we summarize the diversity of these molecules and highlight distinct mechanisms to disrupt the peptidoglycan, giving special attention to molecules that are known or have the potential to be used during interbacterial competitions.

Citing Articles

How Unnatural Amino Acids in Antimicrobial Peptides Change Interactions with Lipid Model Membranes.

Mitra S, Chen M, Stedman F, Hernandez J, Kumble G, Kang X J Phys Chem B. 2024; 128(40):9772-9784.

PMID: 39328031 PMC: 11472314. DOI: 10.1021/acs.jpcb.4c04152.


Engineering Whole-Cell Biosensors for Enhanced Detection of Environmental Antibiotics Using a Synthetic Biology Approach.

Priyadharshini A, Ganesh I, Rangarajalu K, Samuel M, Ravikumar S Indian J Microbiol. 2024; 64(2):402-408.

PMID: 39010990 PMC: 11246489. DOI: 10.1007/s12088-024-01259-w.


Novel non-helical antimicrobial peptides insert into and fuse lipid model membranes.

Mitra S, Chandersekhar B, Li Y, Coopershlyak M, Mahoney M, Evans B Soft Matter. 2024; 20(20):4088-4101.

PMID: 38712559 PMC: 11109824. DOI: 10.1039/d4sm00220b.


Identification of type VI secretion system effector-immunity pairs using structural bioinformatics.

Geller A, Shalom M, Zlotkin D, Blum N, Levy A Mol Syst Biol. 2024; 20(6):702-718.

PMID: 38658795 PMC: 11148199. DOI: 10.1038/s44320-024-00035-8.


Masters of Misdirection: Peptidoglycan Glycosidases in Bacterial Growth.

Weaver A, Taguchi A, Dorr T J Bacteriol. 2023; 205(3):e0042822.

PMID: 36757204 PMC: 10029718. DOI: 10.1128/jb.00428-22.


References
1.
Rumbo C, Gato E, Lopez M, Ruiz de Alegria C, Fernandez-Cuenca F, Martinez-Martinez L . Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother. 2013; 57(11):5247-57. PMC: 3811325. DOI: 10.1128/AAC.00730-13. View

2.
Navaratna M, Sahl H, Tagg J . Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol. 1998; 64(12):4803-8. PMC: 90925. DOI: 10.1128/AEM.64.12.4803-4808.1998. View

3.
Silver L . Challenges of antibacterial discovery. Clin Microbiol Rev. 2011; 24(1):71-109. PMC: 3021209. DOI: 10.1128/CMR.00030-10. View

4.
Abdallah A, Gey van Pittius N, Champion P, Cox J, Luirink J, Vandenbroucke-Grauls C . Type VII secretion--mycobacteria show the way. Nat Rev Microbiol. 2007; 5(11):883-91. DOI: 10.1038/nrmicro1773. View

5.
Schneider T, Gries K, Josten M, Wiedemann I, Pelzer S, Labischinski H . The lipopeptide antibiotic Friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate. Antimicrob Agents Chemother. 2009; 53(4):1610-8. PMC: 2663061. DOI: 10.1128/AAC.01040-08. View